Howard Horn - 23 Feb 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Reporting relationship: CFO
Issuer ticker: VIR
Reported as of: 23 Feb 2023
Net transaction value: -$58,387
SEC form: 4
Accepted by SEC: 24 Feb 2023, 19:36:25 UTC
Prior SEC filing: 21 Feb 2023
Next SEC filing: 10 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Howard Horn

Key filing fact

Howard Horn filed Form 4 for Vir Biotechnology, Inc. (VIR) on 24 Feb 2023.

Key facts

This page summarizes Howard Horn's Form 4 filing for Vir Biotechnology, Inc. (VIR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Feb 2023, 19:36.

Change

Previous filing in this sequence was filed on 21 Feb 2023.
Current net transaction value: -$58,387.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIR transaction

Common Stock

Sale

Transaction value: $58,387
Shares: -2,248
Change %: -0.96%
Price: $25.97
Shares after: 230,712
Date: 23 Feb 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.